MedTrace Logo

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

NCT01726257 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 333

Last updated 2025-02-28

Study results available
· View outcomes & findings →

Summary

The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).

Conditions

  • Abdominal Aortic Aneurysm (AAA)

Interventions

DEVICE

Nellix System

Subjects in this study will receive a Nellix Endovascular Sealing System as part of their intervention.

Sponsors & Collaborators

  • Endologix

    lead INDUSTRY

Principal Investigators

  • Jeffrey Carpenter, MD · Cooper Hospital, Camden, NJ

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2016-06-30
Completion
2022-12-31
FDA Device
Yes

Countries

  • United States
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01726257 on ClinicalTrials.gov